HIGHLIGHTS
- who: Vincenzo Rizza from the Raffaele University, Milan, Italy have published the Article: Atrial Flow Regulator: A New Player for the Treatment of Refractory Heart Failure, in the Journal: (JOURNAL)
- what: The management of drug-refractory HF is challenging.
- future: Studies are necessary to better define long-term hemodynamic consequences of creating a percutaneous inter-atrial shunt.
SUMMARY
Heart failure (HF) is a clinical syndrome characterized by typical symptoms (e_g dyspnoea, orthopnoea or fatigue) and signs (pulmonary crackles or peripheral oedema) caused by a structural and or functional cardiac . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.